{
    "clinical_study": {
        "@rank": "88857", 
        "arm_group": [
            {
                "arm_group_label": "Nimesulide + Pantoprazole", 
                "arm_group_type": "Experimental", 
                "description": "Nimesulide + Pantoprazole- 1 tablet each 12 hours for 7 days"
            }, 
            {
                "arm_group_label": "Nimesulide", 
                "arm_group_type": "Active Comparator", 
                "description": "Nimesulide- 1 tablet each 12 hours for 7 days"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to evaluate the safety of an association with one\n      anti-inflammatory and one gastroprotective agent compared to the anti-inflammatory\n      monotherapy in patients with acute or chronic osteoarticular inflammation."
        }, 
        "brief_title": "Evaluation of Two Therapies for the Treatment of Osteoarticular Inflammation in Dyspeptic Patients", 
        "completion_date": {
            "#text": "September 2014", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Acute and Chronic Inflammation", 
            "Dyspepsia"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Dyspepsia", 
                "Inflammation"
            ]
        }, 
        "detailed_description": {
            "textblock": "-  Double-blind,randomized, multicenter\n\n        -  Experiment duration: 8 days\n\n        -  03 visits (day 0 - screening), (day 1 - randomization), (day 7 - closure)\n\n        -  Evaluate the safety of an association with one anti-inflammatory and one\n           gastroprotective compared to anti-inflammatory monotherapy in patients with acute or\n           chronic osteoarticular inflammation\n\n        -  Adverse events evaluation"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Adults male or female aged \u2265 18 years old;\n\n          -  Comply with all the purposes and procedures of the study by signing and dating the IC\n\n          -  Acute or chronic osteo-articular injury in need of of anti-inflammatory for a period\n             of 7 days\n\n          -  Upper endoscopy with normal or non-erosive esophagitis or gastritis endoscopic\n             enanthematous.\n\n        Exclusion Criteria:\n\n          -  Pregnant women, or women in childbearing age who are not in use effective\n             contraception or intending to become pregnant during the study period History of\n             peptic ulcer or gastric surgery;\n\n               -  Use of Non-steroidal anti-inflammatory (NSAIDs), aspirin, proton pump inhibitor\n                  (PPIs), H2 blocker and antacid in the past 30 days;\n\n               -  Upper endoscopy with erosive lesions or ulcerated lesions of the esophagus,\n                  stomach and / or duodenum;\n\n               -  Contraindication to the use of NSAIDs or PPIs;\n\n               -  Renal or hepatic impairment;"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "65 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "206", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "August 17, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01670552", 
            "org_study_id": "NIPEMS1111"
        }, 
        "intervention": [
            {
                "arm_group_label": "Nimesulide + Pantoprazole", 
                "description": "1 tablet each 12 hours for 7 days", 
                "intervention_name": "Nimesulide + Pantoprazole", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Nimesulide", 
                "description": "1 tablet each 12 hours for 7 days", 
                "intervention_name": "Nimesulide", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Pantoprazole", 
                "Nimesulide"
            ]
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "September 24, 2013", 
        "number_of_arms": "2", 
        "official_title": "Parallel Study, Double-blind, Randomized, to Compare the Safety of Two Therapies for the Treatment of Osteoarticular Inflammation in Dyspeptic Patients.", 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "Brazil: National Health Surveillance Agency", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "June 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Comparison of endoscopic and histological changes of the upper gastrointestinal tract", 
            "safety_issue": "Yes", 
            "time_frame": "7 days"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01670552"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "measure": "Incidence of adverse events and dyspeptic complaints during the study", 
            "safety_issue": "Yes", 
            "time_frame": "7 days"
        }, 
        "source": "EMS", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "EMS", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "October 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "September 2013"
    }
}